A Multicenter and Prospective Study of Screening Retinopathy of Prematurity in China

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine

About this trial

The purpose of the study is to explore the current incidence rate of retinopathy of prematurity (ROP) in China and to explore more appropriate screening criteria for ROP.

Eligibility criteria

Qualifiers

None

Disqualifiers

Death before the first screening;

Death or loss to follow-up before complete retinal vascularization;

Presence of other diseases causing incomplete retinal vascularization, such as familial exudative vitreoretinopathy, incontinentia pigmenti, or Coats disease;

Coexisting conditions affecting the classification or staging of ROP, such as corneal opacity, congenital cataract, persistent fetal vasculature, retinoblastoma, anophthalmia, Terson syndrome, or other ocular infections or diseases;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed